WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more

Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law

Raccontata dastatnews.comfiercepharma.comfaz.net

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
statnews.comStai leggendo1 mesi fa

Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more

Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law

originale
fiercepharma.com1 mesi fa

Lilly, Boehringer to slash at least $1B each from planned investments in Germany

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare initiative, representatives for the companies told Fierce.  | In response to a planned…

Leggi questa versione →

Timeline cronologica

  1. martedì 2 giugno 2026·statnews.com

    Pharmalittle: We're reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more

    Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks

  2. mercoledì 3 giugno 2026·statnews.com

    Pharmalittle: We're reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more

    Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found

originale
faz.net1 mesi fa

Business-Liveticker: Pharmariese Eli Lilly will Investitionen in Deutschland kürzen | FAZ

SpaceX setzt Ausgabepreis für Börsengang +++ Deepseek sichert sich in Finanzierungsrunde offenbar 6,4 Milliarden Euro +++ Bayer steht vor neuer Hürde bei Glyphosat-Vergleich +++ Neuigkeiten im Unternehmen-Liveblog.

Leggi questa versione → originale
  • mercoledì 3 giugno 2026·fiercepharma.com

    Lilly, Boehringer to slash at least $1B each from planned investments in Germany

    Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare initiative, representatives for the companies told…

  • giovedì 4 giugno 2026·faz.net

    Business-Liveticker: Pharmariese Eli Lilly will Investitionen in Deutschland kürzen | FAZ

    SpaceX setzt Ausgabepreis für Börsengang +++ Deepseek sichert sich in Finanzierungsrunde offenbar 6,4 Milliarden Euro +++ Bayer steht vor neuer Hürde bei Glyphosat-Vergleich +++…

  • giovedì 4 giugno 2026·statnews.com

    Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more

    Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law

  • venerdì 5 giugno 2026·statnews.com

    Pharmalittle: We're reading about Roche accusing U.S. of 'blackmail,' a ruling on skinny labels, and more

    Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program